These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37107558)

  • 1. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes.
    Fosu K; Quarshie JT; Sarpong KAN; Aikins AR
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.
    Chatterjee A; Dutta S; Mukherjee S; Mukherjee N; Dutta A; Mukherjee A; Sinha S; Panda CK; Chaudhuri K; Roy AL; Mukhopadhyay K
    BMC Med Genet; 2013 Jan; 14():12. PubMed ID: 23343470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS family of genes in leukemia and Down syndrome.
    Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
    Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.
    Wolvetang EJ; Wilson TJ; Sanij E; Busciglio J; Hatzistavrou T; Seth A; Hertzog PJ; Kola I
    Hum Mol Genet; 2003 Feb; 12(3):247-55. PubMed ID: 12554679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
    Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
    J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.
    Forés-Martos J; Cervera-Vidal R; Chirivella E; Ramos-Jarero A; Climent J
    Front Physiol; 2015; 6():10. PubMed ID: 25698970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.
    Park J; Oh Y; Chung KC
    BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension.
    Galambos C; Minic AD; Bush D; Nguyen D; Dodson B; Seedorf G; Abman SH
    PLoS One; 2016; 11(8):e0159005. PubMed ID: 27487163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
    Wolvetang EW; Bradfield OM; Tymms M; Zavarsek S; Hatzistavrou T; Kola I; Hertzog PJ
    Biochim Biophys Acta; 2003 Jul; 1628(2):105-10. PubMed ID: 12890557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.
    Sun X; Wu Y; Chen B; Zhang Z; Zhou W; Tong Y; Yuan J; Xia K; Gronemeyer H; Flavell RA; Song W
    J Biol Chem; 2011 Mar; 286(11):9049-62. PubMed ID: 21216952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP kinase/ERK kinase 1 (MEK1) phosphorylates regulator of calcineurin 1 (RCAN1) to regulate neuronal differentiation.
    Kim SS; Lee EH; Shin JH; Seo SR
    J Cell Physiol; 2022 Feb; 237(2):1406-1417. PubMed ID: 34647615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
    Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
    J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.
    Martin KR; Layton D; Seach N; Corlett A; Barallobre MJ; Arbonés ML; Boyd RL; Scott B; Pritchard MA
    J Med Genet; 2013 Jul; 50(7):444-54. PubMed ID: 23644448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7.
    Wu Y; Deng Y; Zhang S; Luo Y; Cai F; Zhang Z; Zhou W; Li T; Song W
    Neurobiol Aging; 2015 Jan; 36(1):169-77. PubMed ID: 25194880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.
    Martin KR; Corlett A; Dubach D; Mustafa T; Coleman HA; Parkington HC; Merson TD; Bourne JA; Porta S; Arbonés ML; Finkelstein DI; Pritchard MA
    Hum Mol Genet; 2012 Jul; 21(13):3025-41. PubMed ID: 22511596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association.
    Pelleri MC; Locatelli C; Mattina T; Bonaglia MC; Piazza F; Magini P; Antonaros F; Ramacieri G; Vione B; Vitale L; Seri M; Strippoli P; Cocchi G; Piovesan A; Caracausi M
    BMC Med Genomics; 2022 Dec; 15(1):266. PubMed ID: 36544206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil improves gene targets of Down syndrome in C57BL and BALB/c mice.
    Zmijewski PA; Gao LY; Saxena AR; Chavannes NK; Hushmendy SF; Bhoiwala DL; Crawford DR
    Nutr Res; 2015 May; 35(5):440-8. PubMed ID: 25799055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential allelic distribution of V-ets erythroblastosis virus E26 oncogene homolog2 (ETS2) functional polymorphisms in different group of patients.
    Chatterjee A; Dutta S; Mukherjee S; Mukherjee N; Chandra S; Mukherjee A; Sinha S; Panda CK; Chaudhuri K; Mukhopadyay K
    Gene Expr; 2010; 15(2):61-73. PubMed ID: 21526717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.